Atlas Trials

Emend for Multiple-day Emetogenic Chemotherapy

Clinical trial NCT00711555 · COMPLETED

Trial details

NCT number
NCT00711555
Sponsor
University of Illinois at Chicago
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
NauseaVomiting
Start date
2005-11-01
Primary completion
2008-11-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.